Cannabis Science Forms Military Advisory Board That Will Be Comprised of Distinguished Military Leaders, Military Health Care Providers, Researchers and Educators Headed Up by Lieutenant Colonel, U.S. Army (Ret) Kevin Sullivan
COLORADO SPRINGS, Colo., Dec. 23, 2010 /PRNewswire/ -- Cannabis Science, Inc. (OTC Bulletin Board: CBIS), a pioneering U.S. biotech company developing pharmaceutical cannabis products, announced today that it has formed a Military Advisory Board, that will be comprised of distinguished military leaders, military Health Care Providers, Researchers and Educators.
The Cannabis Science Military Advisory Board will be comprised of individuals with career experience with the Department of Defense (DoD), Department of Veterans Affairs, The Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury and The Department of Health and Human Services.
Under the partnership with Leading Points Corporation and its President, Lieutenant Colonel, U.S. Army (Ret) Kevin Sullivan, the Cannabis Science Military Advisory Board will help identify and develop actionable policies to help ease the burden on veterans serving with debilitating injuries and illnesses. The board will provide an institutionalized conduit for the evolving concerns of military veterans to be brought to the attention of senior policymakers and the public.
LTC (Ret.) Kevin Sullivan stated, "The military advisory board is committed to ensuring servicemembers, veterans and families who are dealing with psychological health conditions such as Post Traumatic Stress Disorder and traumatic brain injury (TBI) challenges have access to all options of quality treatments available. We will represent the company in respect to a number of federal initiatives and insure that the company is positioned to support the development of any federal programs through clinical studies, education and treatment."
Dr. Robert Melamede, PhD., Cannabis Science President and CEO, explained, "As a board, their mission will be to share their knowledge and experience by helping Cannabis Science's senior management team to understand the needs of the military market and to deliver products that meet those needs. As we continue to diversify our company, the U.S. government, and specifically the military and federal government channels, will continue to present us with opportunities for growth. We are excited about this high-level of expertise our Military Advisors will bring to the company, and we look forward to their contributions in helping us represent the brave men and women who have given so much for each of us."
Lt. Col. Sullivan further stated, "In early 2011, we will be submitting a petition that asks the Colorado Department of Public Health and Environment to add PTSD (post-traumatic stress disorder) to the list of conditions for which medical cannabis can be recommended. We are beginning to see a new openness within the federal government to allow the limited and appropriate use of cannabis under a doctor's supervision. We believe our veterans should have the maximum number of treatments available to them, especially with cannabis' proven effectiveness in assisting veterans struggling with chronic and phantom limb pain, sleep disturbance, brain injuries, PTSD, anxiety and depression."
About Leading Points Corporation:
Leading Points Corporation, founded in 2004, specializes in marketing to the military market. They are considered the experts in matters of securing placement of their clients' products in the military exchange store distribution channel as well as special promotions to the military community. The company is headquartered in Centennial, Colorado
About Cannabis Science, Inc.
Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.
Forward Looking Statements
Forward Looking Statements; This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.
Cannabis Science, Inc.
SOURCE Cannabis Science, Inc.